Missense mutations in the MiRP1 gene diminish potassium currents and are associated with long QT syndrome and ventricular fibrillation, revealing a mechanism for acquired arrhythmia.
The discovery of MiRP1 and its mutations provides a genetic mechanism for both congenital and acquired (drug-induced) cardiac arrhythmias via reduced potassium currents.
A novel potassium channel gene has been cloned, characterized, and associated with cardiac arrhythmia. The gene encodes MinK-related peptide 1 (MiRP1), a small integral membrane subunit that assembles with HERG, a pore-forming protein, to alter its function. Unlike channels formed only with HERG, mixed complexes resemble native cardiac IKr channels in their gating, unitary conductance, regulation by potassium, and distinctive biphasic inhibition by the class III antiarrhythmic E-4031. Three missense mutations associated with long QT syndrome and ventricular fibrillation are identified in the gene for MiRP1. Mutants form channels that open slowly and close rapidly, thereby diminishing potassium currents. One variant, associated with clarithromycin-induced arrhythmia, increases channel blockade by the antibiotic. A mechanism for acquired arrhythmia is revealed: genetically based reduction in potassium currents that remains clinically silent until combined with additional stressors.
Abbott et al. (Thu,) conducted a other in Cardiac arrhythmia (long QT syndrome and ventricular fibrillation). MiRP1 gene mutations vs. Wild-type MiRP1 was evaluated on Potassium channel function and association with arrhythmia. Missense mutations in the MiRP1 gene diminish potassium currents and are associated with long QT syndrome and ventricular fibrillation, revealing a mechanism for acquired arrhythmia.